By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 3 June 2024 EATRIS ERIC is the European infrastructure for translational medicine and brings together resources and services for research communities. EATRIS (see external web page) provides access to a vast array of pre-clinical and clinical expertise and facilities that are available from over 150 top-tier

https://www.lp3.lu.se/article/pps-now-associated-academic-centre-eatris - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 25 June 2024 LP3 outreach at the 27th Swedish Conference on Macromolecular Structure & Function (SWEPROT) Sweprot (see external homepage) is the annual meeting of the Swedish society for biochemistry, biophysics and molecular biology (SFBBM, see external homepage), a section of the Swedish Chemical Society a

https://www.lp3.lu.se/article/lp3-conference-tallberg - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 14 August 2024 PPS, including LP3, attended the P4EU meeting earlier this summer at the Helmholtz Center for Infection Research in Braunschweig, Germany. P4EU (Protein Production and Purification Partnership in Europe, see external webpage) is a professional network, whose members engage in various aspects o

https://www.lp3.lu.se/article/pps-p4eu-conference - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 15 October 2024 The distributed national research infrastructure Protein Production Sweden (PPS), where LP3 is included, met for its third annual staff retreat at Skeppsviks Herrgård near Umeå. The 23 staff researchers of PPS attending used the two day meeting to discuss and reflect about the first 2.5 years

https://www.lp3.lu.se/article/lp3-participated-annual-pps-retreat-umea - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 24 October 2024 LP3 is one of three major university research infrastructures selected as university platforms by our rector. The appointment signals that these research infrastructures have high strategic importance for the entire university. The appointments are based on a number of criteria, for example t

https://www.lp3.lu.se/article/lund-university-has-selected-lp3-become-university-platform - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 29 October 2024 LP3 now has a demo unit of Fidabio (Fida Neo instrument) for Flow Induced Dispersion Analysis for protein sample quality, which is available for evaluation purposes the next 3 months. The analysis of sample gives an indication of the protein's health, oligomeric state/complex formation, if it

https://www.lp3.lu.se/article/free-testing-flow-induced-dispersion-analysis-now-lp3 - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 18 November 2024 Four of LP3’s staff participated in the first SciLifeLab Lund retreat in Båstad, 14 to 15th November 2024 with the theme: “Achieving Excellence Together”. The retreat was focused on giving the staff from all SciLifeLab site platforms the opportunity to get to know each other through presenta

https://www.lp3.lu.se/article/lp3-first-scilifelab-lund-retreat - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 21 November 2024 The Swedish NMR Centre in Gothenburg will host a workshop on cell-free protein synthesis, with special focus on applications in NMR spectroscopy. The workshop, which is held in Gothenburg 21-23 Jan 2025 will entail both lectures and practical wet lab work. The idea is that participants bring

https://www.lp3.lu.se/article/cell-free-protein-synthesis-workshop-january-2025 - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 21 January 2025 SciLifeLab Lund, which Lp3 is part of, arranges interesting seminars with presentations of its different units and local core facilities together with user presentations. So please take the opportunity to learn more of our different services which could be useful in you research. The SciLifeL

https://www.lp3.lu.se/article/welcome-scilifelab-seminars - 2025-07-19

By cob-ars [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 23 January 2025 LP3 was presented at the yearly meeting for MAX IV synchrotron users held in January 2025. Dr. Celeste Sele presented two posters about LP3's capabilities within protein crystallisation/biophysics and structure determination as well as protein production within the national research infrastructure Protein

https://www.lp3.lu.se/article/lp3-36th-max-iv-user-meeting - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 17 February 2025 You don't want to miss this! PPS is hosting, and more info on registration will come later! Please follow our PPS linkedin for releases of the preliminary program and registration details-coming soon.Alternatively, see www.pps.gu.se/en or www.p4eu.orgFor urgent enquiries please contact e-mai

https://www.lp3.lu.se/article/heads-next-p4eu-meeting-will-be-gothenburg-25th-27th-august-2025 - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 10 March 2025 In the very last number of LUM, there was a popular science presentation of LP3 and our work. "LP3 has since the start in 2012, produced proteins for around 300 research projects - from drug development to sustainable chemical processes"Read the full article (in Swedish) here on the Lund Univer

https://www.lp3.lu.se/article/article-about-lp3-lund-university-magazine - 2025-07-19

By Heather [dot] Sullivan [at] Biol [dot] lu [dot] se (Heather Sullivan) - published 28 March 2025 LP3 will provide capabilities within protein production, biophysical characterization and protein structure determination to help VIGILANT achieve its goals. VIGILANT: Targeting ER Import And Activation Of Viral Glycoproteins: Towards Broad-Spectrum AntiviralsLP3 will provide capabilities within prot

https://www.lp3.lu.se/article/lp3-collaborates-new-eu-research-project-vigilant - 2025-07-19

By Heather [dot] Sullivan [at] Biol [dot] lu [dot] se (Heather Sullivan) - published 4 April 2025 Registration is now open for the 21st Protein Production and Purification Partnership in Europe Meeting. REGISTRATION is now OPEN for the 21st P4EU Meeting in Gothenburg, 25th-27th August 2025! Hosted this year by the Universities of Lund and Gothenburg of Protein Production Sweden.Information regardi

https://www.lp3.lu.se/article/registration-now-open-21st-p4eu-meeting-gothenburg-aug-25-27th - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 23 June 2025 LP3 attended the 28th Swedish Conference on Macromolecular Structure & Function (SWEPROT) in Tällberg last weekend and presented our capabilities through several posters. Several PPS team members visited the meeting with around 130 other participants from the Swedish protein science community.Mo

https://www.lp3.lu.se/article/lp3-tallberg-conference-2025 - 2025-07-19

By anna [dot] rasmussen [at] biol [dot] lu [dot] se (Anna Andersson Rasmussen) - published 25 June 2025 Several LP3 members presented our capabilities with a poster at the first conference held in Linxs new facilities. The conference was held to celebrate the opening of the LINXS at Brunnshög in the newly build Loop (more info here on Linxs homepage). Several staff members of PPS visited the openi

https://www.lp3.lu.se/article/lp3-inagural-conference-new-linxs - 2025-07-19

Published 18 July 2020 3D structure of Nsp10 from the new corona virus SARS-cov-2. An international collaboration between the Lund Protein Production Platform (LP3), the UCL School of Pharmacy and ESS, through its DEMAX platform, has initiated biophysical and structural studies of three non-structural proteins from the novel coronavirus, SARS CoV-2, the causative agent of COVID-19. Recently we man

https://www.lp3.lu.se/article/collaborative-research-project-corona-virus-proteins - 2025-07-19

Published 8 October 2020 Results from the collaborative corona virus protein research project involvning Lund Protein Production Platform (LP3), the UCL School of Pharmacy and ESS, through its DEMAX platform have been published in the International Journal of Molecular Sciences.

https://www.lp3.lu.se/article/results-collaborative-corona-virus-protein-research-project-published - 2025-07-19

Published 1 July 2019 LP3 activities will be limited during the summer, especially in July and early August. In the meantime, here’s some recommended summer reading:

https://www.lp3.lu.se/article/recommended-summer-reading - 2025-07-19

Published 29 March 2019 FragMAX, a project run in collaboration between LP3, MAXIV, Astra Zeneca and SARomics Biostructures, has been awarded funding from the Swedish Research Council. The project aims to establish a fragment based screening facility, enabling scientists and small companies to screen low molecular weight fragments for binding to target proteins using X-ray crystallography.Read mor

https://www.lp3.lu.se/article/fragmax-awarded-funding-swedish-research-council - 2025-07-19